Trial Profile
A Phase 2, Multi-Center, Evaluator-Blind, Randomized, Vehicle-Controlled Clinical Study to Assess the Safety and Efficacy of IDP-115 in the Treatment of Rosacea
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 May 2014
Price :
$35
*
At a glance
- Drugs IDP 115 (Primary)
- Indications Rosacea
- Focus Therapeutic Use
- Sponsors Dow Pharmaceutical Sciences
- 05 May 2014 New trial record